Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-27 @ 9:20 PM
Study NCT ID:
NCT05938361
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-24
First Post:
2023-05-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
Sponsor:
Clin4all
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-30
First Submit QC Date:
None
Study First Post Date:
2023-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-19
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED